Defiance Daily Target 2x Long LMND ETF
LMNX · ETF
About LMNX
- Issuer
- Defiance
- Expense ratio
- 1.31%
- Assets under management
- $4.12M
- Inception
- Oct 15, 2025
- Asset class
- Equity
- Website
- defianceetfs.com
LMNX key statistics
- Price-earnings ratio
- 0.00
- Average volume
- 34.46K
- Volume
- 17.06K
- Open price
- $9.08
- High today
- $10.00
- Low today
- $9.16
- 52 Week high
- $55.00
- 52 Week low
- $6.90
Defiance Daily Target 2x Long LMND ETF (LMNX) at a glance
Defiance Daily Target 2x Long LMND ETF (LMNX) last traded at $9.16, with a price-to-earnings ratio of 0.00.
Today the fund has traded between $9.16 and $10.00. The current price is 0.0% above the day's low and 8.4% below its high.
Volume so far is 17.06K shares, below the average of 34.46K shares a day.
Over the past year Defiance Daily Target 2x Long LMND ETF has ranged from $6.90 to $55.00, and now sits 5% of the way up that range.
LMNX news
- Press releaseBusiness Wire
Most active stocks
Highest trading volume today
- SHFSSHF Holdings$0.0899−4.36%
- WHLRWheeler Real Estate Investment Trust$0.3597+2.19%
- RBNERobin Energy$0.3978−23.65%
- SDSTStardust Power$0.02−23.66%
- RCTRedCloud Holdings$0.084+1.94%
- WFFWF Holding$0.0929−3.83%
- NWGLCL Workshop Group$0.1522+27.90%
- DKIDarkiris$0.0479−6.08%
- AHTAshford Hospitality Trust$1.79−2.72%
- KORUDirexion Shares ETF Trust$11.34−4.87%
- SOXLDirexion Shares ETF Trust$97.55−1.12%
- SPCXSpace Exploration Technologies$147.79−0.11%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.